Physician profile
Brad D Hamik
NPI 1083868723
$769.54
in general payments reported to CMS, 2019-2025
12 companies · $68.38 in 2025
The $68.38 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.18 · 2020: $89.89 · 2021: $169 · 2022: $144 · 2023: $137 · 2024: $72.74 · 2025: $68.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $212.51 | 2019-2024 | |
| Chiesi USA, INC. | $172.02 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $165.95 | 2019-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $49.93 | 2022-2025 | Exparel, Iovera |
| Abiomed | $42.76 | 2023 | Impella |
| Baxter Healthcare | $24.27 | 2022 | |
| Haemonetics Corporation | $23.82 | 2023 | |
| Artivion, INC. | $19.65 | 2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Cardiac Non-Synergraft |
| Takeda Pharmaceuticals U.S.A., INC. | $16.93 | 2023 | Entyvio |
| Cumberland Pharmaceuticals, INC. | $16.86 | 2024 | Caldolor |
| Acelrx Pharmaceuticals, INC. | $14.94 | 2019 | |
| Pajunk Medical Systems, LP | $9.90 | 2025 | E-Cath II Plus Tsui |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Hamik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.